2 min read
High-dose influenza vaccination remains a cost-effective investment for older adults in the Netherlands
Tanja Fens: 24 June 2026 14:12:34 CEST
Updated health-economic evidence, drawing on data from more than 85 million individuals, confirms that switching from standard-dose to high-dose...